BCL2L1 and rhabdomyosarcoma: As shown in Fig 3C, downstream targeted genes of STAT3 such as CYCLIN D1, SURVIVIN, and BCL-XL in RH30, RD, and RH28 rhabdomyosarcoma cell lines were down-regulated when treated with Bazedoxifene.